Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

STAFFORD, Texas, July 22, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the regulatory approval to expand FLAMINGO-01 into the United Kingdom.

AI in Revenue Cycle Management Market Size to Reach $225.87 Billion by 2035 | SNS Insider

The U.S. AI in Revenue Cycle Management Market is Expected to Reach $90.71 Billion by 2035, While Europe is Projected to Attain $59.82 Billion, Driven by Rising Claim Denials, Healthcare Digitalization, Predictive Analytics, and AI-Powered Revenue Cycle Automation

The U.S. AI in Revenue Cycle Management Market is Expected to Reach $90.71 Billion by 2035, While Europe is Projected to Attain $59.82 Billion, Driven by Rising Claim Denials, Healthcare Digitalization, Predictive Analytics, and AI-Powered Revenue Cycle Automation

Trump Accounts Explained: Proposed U.S. Savings Vehicle Raises Cross-Border Tax Concerns for Canadian-Based Families

New York, NY, July 22, 2026 (GLOBE NEWSWIRE) — Cardinal Point Wealth Management is helping cross-border families navigate the complexities of newly proposed U.S. savings vehicles, commonly referred to as “Trump Accounts,” and highlighting the potential tax and planning pitfalls for those with financial ties to both Canada and the United States.

Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma

Cambridge, UK – 22 July, 2026 – Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first patient has been dosed in its Phase 1/2 dose-escalation and dose-confirmation clinical trial to evaluate the safety and efficacy of HLX-4310, an investigational oral combination of a class I selective HDAC inhibitor and an mTOR inhibitor, in adolescents and adults with relapsed, refractory sarcoma, with a focus on osteosarcoma.

Humanoid Global Highlights Formic’s Role in Launching Robots for America and Announces Leadership and Membership Updates for the U.S. Robotics Coalition

Vancouver, BC & Washington, D.C., July 22, 2026 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBOFWB:0XM1OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to highlight recent developments related to Robots for America (“Robots for America” or the “Coalition”), an industry initiative that was catalyzed by its portfolio company Formic Technologies, Inc. (“Formic”), in which Humanoid Global holds a minority equity interest.

REV Fiber named the Official Internet Partner of LSU Athletics

Louisiana’s largest, locally owned fiber-first internet provider launches a multi-year, all-sports partnership with LSU Athletics ahead of the 2026 football season

Louisiana’s largest, locally owned fiber-first internet provider launches a multi-year, all-sports partnership with LSU Athletics ahead of the 2026 football season

The Hype Marketing Agency Expands Its International Presence

Amsterdam, Netherlands, July 21, 2026 (GLOBE NEWSWIRE) — The Hype Marketing Agency today announced the continued expansion of its international operations in the USA and Europe, strengthening its presence across digital marketing and gaming infrastructure. Headquartered in the Netherlands, the company serves brands, creators, athletes, public figures, and online platforms worldwide as it continues to expand its global footprint.

YRI Fellowship Launches Elite “Top 1% Program” to Engineer Comprehensive University Admission Portfolios for Ambitious Youth

SAN FRANCISCO, CA, July 21, 2026 (GLOBE NEWSWIRE) — The Young Researchers Institute (YRI) has officially announced the launch of its highly exclusive “Top 1% Program,” an intensive, multi-dimensional mentorship initiative designed to transform ambitious middle and high school students into published authors, startup founders, and recognized innovators.

TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise

SINGAPORE, July 21, 2026 (GLOBE NEWSWIRE) — TOP Financial Group Limited (NASDAQ: TOP) (“TOP” or the “Company”), an online brokerage firm specializing in local and foreign equities, futures, and options products, today announced that the outstanding warrants to purchase up to 428,862,444 Class A ordinary shares of the Company, issued in connection with its recently completed private placement, have been exercised in full on a cashless basis. The cashless exercise resulted in the cancellation of all remaining outstanding placement warrants. The Company issued an aggregate of 360,534,431 Class A ordinary shares upon exercise. As a result of the exercise, all of the outstanding warrants were canceled and are no longer outstanding. The Company did not receive any cash proceeds from the exercise.